Concepedia

Patrick Marcellin

PM

Statistics

Publications

380

Citations

56.6K

H-Index

114

Active since

1989

Affiliations

Hôpital Beaujon(Current)

Inserm

Université Paris Cité

Assistance Publique – Hôpitaux de Paris

Sorbonne Université

Patrick Marcellin is an author at Hôpital Beaujon specializing in viral hepatitis, antiviral therapy, and liver disease.

ORCID

Publications per year

1989–2023

380

Publications

380

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

Ira M. Jacobson, John G. McHutchison, Geoffrey Dusheiko et al. · New England Journal of Medicine · 2011 · 2.4K citations · Full text

, , +17

Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus

Thierry Poynard, Patrick Marcellin, Samuel S. Lee et al. · The Lancet · 1998 · 2.3K citations

, , +17

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

Patrick Marcellin, Edward Gane, Nezam H. Afdhal et al. · The Lancet · 2012 · 1.8K citations

, , +16

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

Nezam H. Afdhal, Stefan Zeuzem, Paul Y. Kwo et al. · New England Journal of Medicine · 2014 · 1.7K citations · Full text

, , +17

Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection

Bruce R. Bacon, Stuart C. Gordon, Eric Lawitz et al. · New England Journal of Medicine · 2011 · 1.6K citations · Full text

, , +17

1–5 of 380